Jay S. Duker - 07 Sep 2022 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EYPT	Stock Option (Right to Buy)	Award	$0	+65,300		$0.000000	65,300	07 Sep 2022	Common Stock	65,300	$9.45	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option to purchase will vest and become exercisable over a three year period as follows: 50% at the one year anniversary of grant and then ratably over the remaining twenty-four months